Tevogen Bio

Tevogen Bio Appoints IT Expert and Leader Mittul Mehta as Chief Information Officer and Head of Tevogen.ai Initiative

October 23, 2023 04:35 PM Eastern Daylight Time WARREN, N.J.–(BUSINESS WIRE)–Tevogen Bio Inc. (“Tevogen Bio”) today announced the appointment of Mittul Mehta as Chief Information Officer (CIO) and Head of Tevogen.ai, the newly launched initiative focused on harnessing the potential of artificial intelligence (AI) for the enhancement of drug discovery, development, manufacturing, distribution, and patient access. “I am excited to join Tevogen Bio at such a … Continue reading Tevogen Bio Appoints IT Expert and Leader Mittul Mehta as Chief Information Officer and Head of Tevogen.ai Initiative

DOMPÉ FARMACEUTICI

Dompé farmaceutici Appoints Shannon K. Sullivan as Chief Commercial Officer Biotech

October 10, 2023 08:00 AM Eastern Daylight Time MILAN, Italy & SAN MATEO, Calif.–(BUSINESS WIRE)–Dompé, a leading biopharmaceutical company with operations in Italy and the US, today announced the appointment of Shannon K. Sullivan as Chief Commercial Officer (CCO), effective immediately. “We are thrilled to welcome Shannon to Dompé as our new Chief Commercial Officer”Tweet this Sullivan is a highly accomplished and respected leader in … Continue reading Dompé farmaceutici Appoints Shannon K. Sullivan as Chief Commercial Officer Biotech

Sibylla Biotech

Sibylla Biotech Appoints Sonia Poli as Chief Scientific Officer

October 10, 2023 05:00 AM Eastern Daylight Time MILAN – Sibylla Biotech today announces the appointment of Sonia Poli, Ph.D., as Chief Scientific Officer (CSO). Dr. Poli brings more than two decades of international experience in pharmaceutical research and development, with broad knowledge spanning small molecule drug design, translational science, and early- to late-stage clinical development. As a seasoned pharmaceutical R&D executive, Dr. Poli has held … Continue reading Sibylla Biotech Appoints Sonia Poli as Chief Scientific Officer

Fractyl Health

Fractyl Health Welcomes Dr. Timothy Kieffer as Chief Scientific Officer

Seasoned Expert Joins to Drive Fractyl’s Pioneering Mission Forward with its Revita® and Rejuva® Programs for Type 2 Diabetes and Obesity Dr. Kieffer’s Stellar Track Record Spans Pioneering Academic Research in Diabetes Mechanisms and Industry Experience with Company Formation and Leadership September 14, 2023 10:08 AM Eastern Daylight Time LEXINGTON, Mass.–(BUSINESS WIRE)–Fractyl Health, a metabolic therapeutics company focused on pioneering new approaches to the treatment of metabolic … Continue reading Fractyl Health Welcomes Dr. Timothy Kieffer as Chief Scientific Officer